SCHEMBL7186280

SCHEMBL7186280

CC(C)Oc1ccc(C(C)(C)C)c(OC(C)C)c1/C=C/C(=O)c1ccc(OCOC(=O)C(C)(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.37
MAOB P27338 6/20 0.36
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 2/20 0.36
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAOA P21397 1/20 0.34
TNFRSF1A P19438 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186283 1.00 PPARA (0.37) PPARAMAOBCYP1A1CYP1B1KDM4E
SCHEMBL7185125 0.90 PPARA (0.38) PPARAMAOBCYP1A1CYP1B1KDM4E
SCHEMBL7185131 0.90 PPARA (0.38) PPARAMAOBCYP1A1CYP1B1KDM4E
SCHEMBL7183543 0.88 TNFRSF1A (0.39) PPARAMAOBCYP1A1CYP1B1KDM4E
SCHEMBL7183536 0.88 TNFRSF1A (0.39) PPARAMAOBCYP1A1CYP1B1KDM4E
SCHEMBL7178953 0.87 PTPN1 (0.42) PPARAKDM4ELMNAMAPTALDH1A1
SCHEMBL7181168 0.87 PTPN1 (0.42)
SCHEMBL7178943 0.87 PTPN1 (0.42) PPARAKDM4ELMNAMAPTALDH1A1
SCHEMBL7181160 0.87 PTPN1 (0.42)
SCHEMBL7184634 0.87 ELANE (0.41) TNFRSF1AABCG2PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed